[Nivaline in neurological therapy (report of 100 cases)].
D000328:Adult; D000368:Aged; D002493:Central Nervous System Diseases / Q000188:drug therapy; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D002986:Clinical Trials as Topic; D005260:Female; D005702:Galantamine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D009468:Neuromuscular Diseases / Q000188:drug therapy*; D010243:Paralysis / Q000188:drug therapy; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy
D005702:Galantamine
Erfahrungen mit Nivalin in der neurologischen Therapie (Bericht über 100 fälle.